Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Bullish
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | BSX | JNJ |
|---|
| Close | 43.91 | 267.28 |
| Market Cap | $63.6B | $644B |
| 1M | −14.62% | +1.87% |
| P/E (TTM) | 17.3 | 30.6 |
| Forward P/E | 13.4 | 20.7 |
| P/E 5-Yr Percentile | 0 | 90 |
| P/S | 3.0 | 6.6 |
| P/B | 2.6 | 7.6 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $5.4B | $25.3B |
| Revenue YoY | +7.5% | +6.6% |
| Gross Margin | 70.7% | 68.2% |
| Latest Quarter EPS | 0.61 | 2.27 |
| Avg Post-Earnings Move | ±1.5% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 1.25% |
| 90-Day Net Insider Buying | +$9.5M | −$67.8M |
BSX · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
